Clinical Trials Logo

Clinical Trial Summary

We aim to measure the impact of a transition program in congenital cardiology in terms of health-related quality of life.

Clinical Trial Description

The number of adults with congenital heart diseases (CHD) is increasing. However, many young adults are lost to follow-up even in experienced tertiary care centers. American and European guidelines recommend to improve the management of young adults with CHD. Structured therapeutic education programs are therefore needed to optimize the transfer to adult healthcare. Our tertiary care CHD center recently implemented a transition program and simultaneously we decided to measure its impact. Indeed we need data from randomized trials in this filed. After previous controlled quality of life studies among children and adults with CHD, we chose to use the health-related quality of life (HR-QoL) as primary endpoint in this randomized study to focus on patient related outcomes.

We assume that patients who participate in our program will improve their quality of life compared to controls. If we demonstrate the benefit of our program, it will have important consequences for patients with CHD and eventually for patients with other chronic medical conditions. ;

Study Design

Related Conditions & MeSH terms

NCT number NCT03005626
Study type Interventional
Source University Hospital, Montpellier
Status Recruiting
Phase N/A
Start date January 2017
Completion date December 2020

See also
  Status Clinical Trial Phase
Unknown status NCT01450956 - The Protective Effects of Sevoflurane in Pediatric Cardiac Surgery N/A
Recruiting NCT02503267 - "Incidence and Consequences of Disorders of Glycosylation in Patients With Conotruncal and Septal Heart Defects" N/A
Recruiting NCT03437148 - Non-Invasive Shunt Quantification in Interatrial Communication N/A
Completed NCT01619982 - Pre-operative Prophylaxis With Vancomycin and Cefazolin in Pediatric Cardiovascular Surgery Patients Phase 4
Recruiting NCT02542683 - Physical Activity and Cognitive Development in Children
Enrolling by invitation NCT02527811 - Ulinastatin Injection in in Pediatric Patients Undergoing Open Heart Surgery Phase 4